Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 05 Sept 2012 for ALLOS THERAPEUTICS INC, €414k.
Insider track record
Disclosed buys
0
Disclosed sells
8
Signal history
No signal scores available.
Michael E. Schick: trading record in brief
Michael E. Schick discloses dealings in Allos Therapeutics Inc to SEC (Form 4). Between 20 October 2010 and 4 September 2012, the trades on record add up to 12 filings.
Every open-market trade on record is a sale: 8 sales worth €25k. The rest of the record consists of 3 share grants. Since January 2012: no purchases and 4 sales on the market.
The latest filing, published on 5 September 2012, reports a transaction of €414k in Allos Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael E. Schick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
285,113 shares@ US$1.82Common StockSEC:0001127602-12-025794:0
697 shares@ US$1.78Common StockSEC:0001127602-12-022208:0
135,545 shares0Common StockSEC:0001127602-12-008999:0
3,894 shares@ US$1.52Common StockSEC:0001127602-12-008999:1
3,960 shares@ US$1.48Common StockSEC:0001127602-12-008999:2
1,645 shares@ US$1.58Common StockSEC:0001127602-12-008152:0
8,033 shares@ US$1.44Common StockSEC:0001127602-11-029990:0
140 shares@ US$1.43Common StockSEC:0001127602-11-029990:1
730 shares@ US$2.06Common StockSEC:0001127602-11-021382:0
65,000 shares0Common StockSEC:0001127602-11-008488:0
1,570 shares@ US$3.25Common StockSEC:0001127602-11-007733:0
78,300 shares0Common StockSEC:0001127602-10-025907:0
12 of 12 declarations
